The following Terms and Conditions apply to your participation in any Patient Support Programme (Programme) sponsored by GlaxoSmithKline (GSK) and managed by Partizan Worldwide Pty Ltd (Partizan) (‘us’, ‘we’ or ‘our’).
Please read these Terms and Conditions and the NUSTART Programme Privacy Policy. It is your right to refuse to agree to the terms and conditions outlined here; however, if you do not agree, you may not be able to participate in the NUSTART Programme. If you have any questions or require additional information, please speak to your doctor, or contact the NUSTART Programme Coordinator on 0800 111 059.
Your enrolment and use of the NUSTART Programme shall constitute acceptance of the following terms and conditions:
You may only access and use the Programme in accordance with these Terms and other instructions that we may provide you with.
You understand and acknowledge that involvement in the NUSTART Programme is designed to complement and support the prescribing instructions of your healthcare professional and does not replace your usual medical care. You must contact your Healthcare Professional for any queries regarding your treatment or condition.
You confirm that you are eligible to participate in the Programme on the basis that you are being prescribed a GSK product associated with the NUSTART Programme. If you are unsure, please contact your Healthcare Professional for further information. If you are under 18, parental or carer consent must be provided.
We reserve the right to exclude participants who are not eligible to use the Programme.
By enrolling in the NUSTART Programme, you also consent to the NUSTART Programme nurses corresponding with members of your healthcare team (including your prescribing doctor) to provide them with information relevant to your healthcare management and progress.
By participating in the NUSTART Programme, you consent to the NUSTART support team corresponding with you (by phone, email, SMS, websites or digital applications), to provide you with information relevant to your status and/or the support services that we will provide to you.
You give permission for the NUSTART Programme Coordinator, GSK, or a third party acting on its behalf, to contact your Healthcare Professional should you experience an adverse event.
If applicable, you give permission for a NUSTART Programme Coordinator to contact your nominated medical clinic, community pharmacy and/or hospital pharmacy to discuss the ongoing administration of your prescribed GSK medication with your doctor or practice nurse, AND/OR to train you/your nominated carer to administer your prescribed GSK medication.
By continuing in the Programme you understand and agree for adverse events involving GSK products to be reported to Partizan Health and that GSK may contact you for further information relating to Adverse Events, if required.
Services provided under the Programme may vary depending on:
Patient services provided under the Programme may include any of the following:
Participant enrolment into the NUSTART Programme can occur through the following channels:
Upon receipt of your enrolment request, the NUSTART Programme Team will verify your eligibility before your enrolment can be accepted.
By providing your personal information you consent to Partizan collecting, using and storing your personal information in accordance with the NUSTART Programme Privacy Policy available at www.nustart.co.nz/patient-privacy (including your name, age, contact details; as well as, sensitive information relating to the GSK treatment you are prescribed or your medical condition) in accordance with the NUSTART Programme Terms and Conditions and the NUSTART Programme Privacy Policy.
Partizan uses your personal information to manage your participation in the Programme. Partizan will not use your personal information for any other purposes unless we have your consent to do so or we are required to do so by law. If you do not provide personal information when requested, Partizan may not be able to manage your participation in the Programme and, as a result, you may not be able to participate.
Partizan may collect and share personal information directly from you, and also from your prescribing specialist. Partizan may use your personal information to contact you as necessary to clarify certain aspects of your personal information and/or to review your experience regarding treatment of your condition(s), participation in the NUSTART Programme, and your interest in participating in market research. Partizan may also disclose your personal information to other persons involved with the NUSTART Programme, such as third party service providers, in accordance with the NUSTART Programme Privacy Policy (e.g. mailhouse suppliers responsible for posting out NUSTART Programme materials).
Your personal information will be stored securely in a Programme database in accordance with the NUSTART Programme Terms and Conditions and the NUSTART Programme Privacy Policy. Partizan takes reasonable steps to protect such personal information from misuse, interference, loss and unauthorised access, modification or disclosure in accordance with the privacy laws of Australia and New Zealand, as applicable.
Your personal information will be handled in accordance with the NUSTART Programme Privacy Policy which details (amongst other things) how you can access, correct or complain about the handling of your personal information, and how Partizan will respond to your requests or complaints. If you have any questions or if you would like a copy of the NUSTART Programme Privacy Policy, or if you would like to see, correct or delete your records or if you have any queries or complaints, please contact Partizan at any time by calling +61 2 8373 7400 or writing to the team at Partizan, 54 Victoria Street, McMahons Point NSW 2060 or emailing the team at support@nustart.co.nz.
DATA SHARING WITH GSK: Any adverse events that Partizan is made aware of that arise from taking or using a GSK Product will be reported to GSK and/or its agents for the purpose of reporting this information to the appropriate regulatory notification body and/or in accordance with GSK’s adverse event reporting processes. De-identified amalgamated information relating to your participation in the NUSTART Programme will be collated into a report for GSK. GSK may use this information for analysis and may publish it in reports or medical publications. You will not be able to be identified in any form of report or publication. Any personal information collected by Partizan that is shared with GSK will be handled in accordance with GSK’s Privacy Policy available at: https://privacy.gsk.com/en-nz/privacy-notice/privacy-principles/.
You have the right to opt out of the NUSTART Programme at any time by calling the NUSTART Programme Coordinator on 0800 111 059 or writing to the NUSTART Programme at support@nustart.co.nz, or by contacting your Healthcare Professional. We may also suspend or cancel your access to the Programme at any time without advance notice and for any reason, although we will use reasonable efforts to provide you with notice wherever practicable.
We reserve our right to modify these Terms at any time, including Programme eligibility requirements. We will use reasonable endeavours to ensure that you are alerted to changes, such as contacting you via email. Your subsequent continued participation in the Programme after such changes have been made will constitute acceptance of the new Terms.
We may also update, improve or otherwise modify the software and the Programme from time to time. If that happens, you may need to download or install updates of the software in order to continue using the Programmes.
If you have any questions about the Programme or these Terms, please contact the NUSTART Programme support team by phone or email at 0800 111 059 and support@nustart.co.nz.
If you have questions regarding your medical treatment, please contact your treating Healthcare Professional.
TAPS NP 20061 NX-NZ-MPL-BRF-230002. Date of approval: October 2023. Date of Expiry: October 2025.